Insider Buying: GSK plc (LON:GSK) Insider Purchases 536 Shares of Stock

GSK plc (LON:GSK - Get Free Report) insider Wendy Becker acquired 536 shares of GSK stock in a transaction dated Thursday, March 20th. The stock was purchased at an average price of GBX 1,515 ($19.58) per share, for a total transaction of £8,120.40 ($10,492.83).

GSK Stock Performance

Shares of LON GSK traded up GBX 3 ($0.04) during mid-day trading on Tuesday, hitting GBX 1,488 ($19.23). 1,543,491,375 shares of the company were exchanged, compared to its average volume of 45,001,945. The stock has a 50 day simple moving average of GBX 1,444.51 and a 200-day simple moving average of GBX 1,437.78. GSK plc has a 1-year low of GBX 1,282.50 ($16.57) and a 1-year high of GBX 1,823.50 ($23.56). The company has a quick ratio of 0.73, a current ratio of 0.81 and a debt-to-equity ratio of 114.64. The firm has a market cap of £60.38 billion, a price-to-earnings ratio of 24.04, a price-to-earnings-growth ratio of 1.24 and a beta of 0.31.

GSK (LON:GSK - Get Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The company reported GBX 23.20 ($0.30) earnings per share (EPS) for the quarter. GSK had a net margin of 8.02% and a return on equity of 18.08%. On average, sell-side analysts forecast that GSK plc will post 175.980975 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on GSK. Berenberg Bank cut their price objective on shares of GSK from GBX 1,820 ($23.52) to GBX 1,600 ($20.67) and set a "buy" rating on the stock in a report on Friday, November 29th. JPMorgan Chase & Co. reiterated an "underweight" rating on shares of GSK in a research note on Tuesday, January 7th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and five have issued a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of GBX 1,805.83 ($23.33).

Remove Ads

GSK Company Profile

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.